Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.

[1]  H. W. Clark,et al.  United States Government Oversight and Regulation of Medication Assisted Treatment for the Treatment of Opioid Dependence , 2009 .

[2]  C. Cunningham,et al.  Factors affecting willingness to provide buprenorphine treatment. , 2009, Journal of substance abuse treatment.

[3]  K. Levit,et al.  Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. , 2009, Drug and alcohol dependence.

[4]  Declan T. Barry,et al.  Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study , 2009, Journal of General Internal Medicine.

[5]  C. Thomas,et al.  Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists. , 2008, Psychiatric services.

[6]  D. Cheng,et al.  Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers , 2008, Journal of General Internal Medicine.

[7]  F. Levin,et al.  Evaluation of a Combined Online and in Person Training in the Use of Buprenorphine , 2006, Substance abuse.

[8]  M. Pantalon,et al.  Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. , 2006, The New England journal of medicine.

[9]  H. Heit,et al.  Office-based treatment of opiate addiction. , 2003, The New England journal of medicine.

[10]  W. Ling,et al.  Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. , 2003, The New England journal of medicine.

[11]  S. Walsh,et al.  The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. , 2003, Drug and alcohol dependence.

[12]  P. O'Connor,et al.  Clinical practice. Office-based treatment of opioid-dependent patients. , 2002, The New England journal of medicine.

[13]  W. Ling,et al.  Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. , 1998, Addiction.

[14]  D A Asch,et al.  Response rates to mail surveys published in medical journals. , 1997, Journal of clinical epidemiology.

[15]  A. Malhotra,et al.  Cases of buprenorphine abuse in India , 1992, Acta psychiatrica Scandinavica.

[16]  J. Jaffe,et al.  A controlled trial of buprenorphine treatment for opioid dependence. , 1992, JAMA.

[17]  R. Hammersley,et al.  The use of buprenorphine and temazepam by drug injectors. , 1991, Journal of addictive diseases.

[18]  A. Campbell,et al.  Buprenorphine abuse among opiate addicts. , 1988, British journal of addiction.

[19]  K. Simpson,et al.  Response rates , 1987 .

[20]  J. Mendelson,et al.  Behavioral pharmacology of buprenorphine. , 1985, Drug and alcohol dependence.

[21]  R. Doll.  The controlled trial. , 1984, Postgraduate medical journal.

[22]  Johnson Ct.  Alkaline battery ingestion. , 1983 .

[23]  I. Harper.  Temgesic abuse. , 1983, The New Zealand medical journal.

[24]  C. O. Kennedy.  A controlled trial , 1971, British Homeopathic Journal.

[25]  E. Rogers,et al.  Diffusion of Innovations , 1964 .